tumor necrosis factor-alpha
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for tumor necrosis factor-alpha, covering 2008-03-04 to 2008-03-04. Get the full timeline:
Most recent: Clinical Trial Update: A Randomized Phase III Trial of Hyperthermic Isolated Limb Perfusion With Melphalan, Tumor Necrosis Factor, and Interferon-Gamma in Patients With Locally Advanced Extremity Melanoma [Phase 3]